超广角荧光血管造影定量渗漏参数与非增殖性糖尿病视网膜病变临床结局
本研究为DRCR Retina Network Protocol AA临床试验的事后分析,纳入537只非增殖性糖尿病视网膜病变(NPDR)眼,评估超广角荧光血管造影(UWF-FA)渗漏指数与4年糖尿病视网膜病变严重程度量表(DRSS)恶化、玻璃体出血(VH)及增殖性糖尿病视网膜病变(PDR)的关系。基线渗漏指数及1年时渗漏增加≥1%均与DRSS恶化、VH和PDR风险升高相关。
要点
- 基线渗漏指数每增加1%,4年DRSS恶化风险增加(HR 1.09)。
- 1年渗漏增加≥1%者4年DRSS恶化率为61%,未增加者为33%。
- 基线渗漏及1年渗漏增加≥1%均与VH和PDR发生相关。
核心结论
- 在NPDR眼中,基线渗漏较高及基线至1年渗漏增加与DRSS恶化及视力威胁并发症(包括VH和PDR)风险升高相关。
- 定量渗漏评估在基线和随访中是有前景的预测糖尿病视网膜病变严重程度和进展的生物标志物。
研究设计与样本
- 本研究为DRCR Retina Network Protocol AA临床试验的事后队列分析。
- 纳入537只眼(363名参与者),平均(SD)年龄61(12)岁,183名(50%)男性、180名(50%)女性。
- 数据收集时间为2015年2月至2020年3月,分析时间为2023年6月至2024年4月。
- DR或糖尿病黄斑水肿的治疗由研究者自行决定。
- 主要结局为4年内DRSS恶化≥2步、玻璃体出血和PDR的时间。
主要发现
- 基线渗漏指数平均(SD)为3.5%(3.9%)。
- 基线渗漏指数与4年DRSS恶化相关(每增加1%的HR为1.09;95%CI 1.05-1.13;P < .001)。
- 1年时453只眼中114只(25%)渗漏较基线绝对增加≥1%。
- 1年渗漏增加≥1%与4年DRSS恶化风险升高相关(61% vs 33%;HR 2.63;95%CI 1.90-3.64;P < .001)。
- 基线渗漏及1年渗漏增加≥1%也与VH和PDR的发生相关。
关键数值与推荐
- 渗漏指数定义为UWF-FA上可分析视网膜中渗漏面积除以总面积。
- 基线渗漏指数每增加1%,4年DRSS恶化HR为1.09(95%CI 1.05-1.13;P < .001)。
- 1年渗漏绝对增加≥1%者4年DRSS恶化率为61%,未增加者为33%(HR 2.63;95%CI 1.90-3.64;P < .001)。
临床怎么用
- 可考虑在NPDR患者基线和随访中采用UWF-FA定量渗漏指数评估疾病进展风险。
- 1年内渗漏指数较基线增加≥1%提示DRSS恶化及VH、PDR风险升高,可加强监测。
- 定量渗漏评估可为临床和临床试验提供连续的视网膜渗漏严重程度尺度。
局限性
- 本研究为临床试验的事后分析。
- DR或糖尿病黄斑水肿治疗由研究者自行决定,可能影响结局评估。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: This study could facilitate the generation of automated quantitative assessments, providing clinicians and clinical trials with a continuous severity scale of retinal leakage to improve the prediction of future diabetic retinopathy (DR) worsening. OBJECTIVE: To examine ultra-widefield fluorescein angiography (UWF-FA) retinal leakage associated with DR progression and complications. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was a post hoc analysis of the DRCR Retina Network Protocol AA clinical trial. Participants were adults with nonproliferative diabetic retinopathy (NPDR). Data was collected from February 2015 to March 2020. Analysis was performed June 2023 to April 2024. INTERVENTIONS: Treatment of DR or diabetic macular edema was at the investigator's discretion. MAIN OUTCOMES AND MEASURES: Time to Diabetic Retinopathy Severity Scale (DRSS) worsening of 2 or more steps, vitreous hemorrhage (VH), and proliferative diabetic retinopathy (PDR) over 4 years. Baseline and 1-year leakage index, calculated as the area with leakage divided by the total area in the analyzable retina on UWF-FA, were evaluated as risk factors. RESULTS: Among 537 eyes (363 participants; mean [SD] age, 61 [12] years; 183 [50%] male, 180 [50%] female), the baseline leakage index (mean [SD], 3.5% [3.9%]) was associated with DRSS worsening over 4 years (hazard ratio [HR] for 1% increase, 1.09; 95% CI, 1.05-1.13; P < .001). At 1 year, 114 of 453 eyes (25%) had an absolute leakage increase 1% or greater from baseline, which was associated with a higher risk of DRSS worsening over 4 years (61% vs 33%; HR, 2.63; 95% CI, 1.90-3.64; P < .001). Baseline leakage and a 1% or greater increase at 1 year were also associated with development of VH and PDR. CONCLUSIONS AND RELEVANCE: In eyes with NPDR, higher leakage at baseline and an increase from baseline to 1 year were associated with greater risk of DRSS worsening and vision-threatening complications, including VH and PDR. These findings support quantitative leakage assessment at baseline and over time as a promising biomarker for predicting the severity and progression of diabetic retinopathy.
引用
- Ehlers JP, Josic K, Aiello LP, et al. Ultra-Widefield Fluorescein Angiographic Quantitative Leakage Parameters and Clinical Outcomes in Nonproliferative Diabetic Retinopathy. JAMA Ophthalmol. 2026. PMID: 41609778. doi:10.1001/jamaophthalmol.2025.5658
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。